
|Articles|January 1, 2002
Supplements and Featured Publications
- Symposium Reporter - Lipid Management
- Volume 8
- Issue 1 Symp
Dyslipidemia of Insulin Resistance Syndrome Explained; Need for Treatment to Reduce Risk Emphasized
Author(s)Henry N. Ginsberg, MD
Advertisement
Articles in this issue
almost 24 years ago
Review of Clinical trial Data Reaffirms Safety of Statin Therapyalmost 24 years ago
Protective Effects of HDL-C and Need to Raise Low Levels Exploredalmost 24 years ago
Question and Answeralmost 24 years ago
New Cholesterol Guidelines Emphasize Risk AssessmentNewsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
2025 Hypertension Guideline Updates Presented at AHA Scientific Sessions
2
Non-Invasive Tests Show Promise for Tracking Treatment Response in Semaglutide MASH Trial
3
Inside the VA’s Hub-and-Spoke Model for Multiple Sclerosis Care: Rebecca Spain, MD
4
Newly Identified RTEL1 Variant Could Broaden Genetic Landscape of Familial PF
5















































